New: "He ask that the court keep the current trial
New: "He ask that the court keep the current trial date"
"Dr. Kazempor dropped his request for e-mails in the 2019 and 2018 intervals that were used to collect the original custodians"
The full filing is on ST & thanks Jesse21SD!!
Yea, i bet he is wanting to stop the discovery of those.
It's like saying to Sidley ---- can you put the spanking im about to recieve, on a timer by chance.
His own request kicked his butt....
& i love that we saw the FDA did not "hate" Cytodyn.
Stupid stuff during covid, but i've got another take on that too.... but on this case, it's back to original. : )
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...
Continue Reading
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...
Continue Reading
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue Reading
Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...
Continue Reading
Top 5 Most Recently Viewed Articles
Riding the Mobile Wave: A New Era in Digital Marketing Folks, GeeLark's latest move is like a sledgehammer to an old wall. Smashed it with their recent rollout of a unified Browser and Cloud Phone platform. This isn't just upgrading the toolbox—it's overhauling the whole workshop. As someone who's seen enough tech promises fizzle, this one might actually stick....
Continue Reading
Seven & i Holdings Plans Major Expansion in North America Japan's Seven & i Holdings has unveiled its ambitious plan to establish 500 new convenience stores in the United States and Canada by 2027. This strategic move comes as the company seeks to solidify its presence in the North American market and compete against local and international convenience store chains....
Continue Reading
Bitcoin's Enduring Presence in Russia Not long ago, Russian President Vladimir Putin took a bold stance by declaring that Bitcoin could not be banned, regardless of any attempts by governments around the globe. This declaration underscored a potential shift in the country's approach to cryptocurrency amidst the backdrop of escalating international sanctions. Putin's...
Continue Reading
Jumptuit's Progress in Artificial Intelligence Technology Jumptuit, a prominent company in the field of AI research and development, has recently marked a significant milestone in its innovative journey. The U.S. Patent and Trademark Office (USPTO) has granted Jumptuit a Notice of Allowance, enhancing its protection for cutting-edge AI Search Technology. This development...
Continue Reading
Harbour BioMed Shares Exciting Results for HBM1020 Harbour BioMed, a global biopharmaceutical company dedicated to creating groundbreaking antibody therapeutics, has reached significant milestones in its clinical research. The company recently shared incredible clinical data on HBM1020, a first-of-its-kind fully human anti-B7H7/HHLA2 monoclonal antibody. This information...
Continue Reading